Nkgen BiotechNKGN

13F holders, Q2 2024 (June 30)
17holders +4
6new positions
2sold out
$1.24avg. 13F price*

At the end of Q2 2024, 17 institutions reported holding Nkgen Biotech Inc. (NKGN) in their 13F filings, up 4 from Q1 2024. 6 opened new positions and 2 sold out. The largest holders were Meteora Capital, LLC ($1.5M), Polar Asset Management Partners Inc. ($1.3M) and University of Chicago ($699K).

Company
Nkgen Biotech Inc.
CUSIP
65488A101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2024: 13Q1 2024Q2 2024: 17Q2 2024Q3 2024: 19Q3 2024Q4 2024: 25Q4 2024Q1 2025: 3Q1 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions6$497K
Exits2$32K

All 13F filers, Q1 2024 → Q2 2024: 455,514 shares bought and 57,519 shares sold, net +397,995 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 17 holders

Meteora Capital, LLC 0.28% Reduce -3.3% 1,167,990 $1.5M
Polar Asset Management Partners Inc. 0.05% No change 1,080,000 $1.3M
University of Chicago 0.54% No change 550,000 $699K
Diametric Capital, LP 0.23% New 333,334 $423K
Geode Capital Management, LLC 0.00% Add +28.2% 68,439 $87K
Vanguard Group Inc. 0.00% No change 53,804 $68K
UBS Group AG 0.00% Add +295.1% 43,817 $56K
Northern Trust Corp. 0.00% Add +85.0% 29,082 $37K
Virtu Financial LLC 0.00% New 18,917 $24K
Sequoia Financial Advisors, LLC 0.00% Add +15.6% 18,500 $23K
BlackRock Inc. 0.00% New 16,966 $22K
State Street Corp. 0.00% New 11,200 $14K
HRT Financial LP 0.00% New 11,389 $14K
Towneley Capital Management, Inc / DE 0.00% No change 10,000 $13K
Tower Research Capital LLC (TRC) 0.00% Reduce -24.6% 2,885 $4K
Federation des caisses Desjardins du Quebec 0.00% No change 500 $635
Bank of America Corp. 0.00% New 50 $64

"% of holder's portfolio" is NKGN's weight in each manager's 13F, not the share of Nkgen Biotech Inc. the manager owns.